<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0002055'>Diabetes</z:mp> is classified clinically into two types: type 1 and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> is an autoimmune <z:mp ids='MP_0002055'>diabetes</z:mp>, whereas, in contrast, type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> is nonautoimmune </plain></SENT>
<SENT sid="2" pm="."><plain>However, there is a group of phenotypic adult type 2 diabetic patients ( approximately 10%) who have islet autoantibodies similar to type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>These patients are said to have latent autoimmune <z:mp ids='MP_0002055'>diabetes</z:mp> in adults (LADA) or type 1.5 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>T-cells reacting with islet proteins have been demonstrated in type 1 and type 1.5 diabetic patients </plain></SENT>
<SENT sid="5" pm="."><plain>In contrast, classic autoantibody-negative type 2 diabetic patients are also negative for T-cell responses to islet proteins </plain></SENT>
<SENT sid="6" pm="."><plain>Therefore, we questioned whether type 1 and type 1.5 <z:mp ids='MP_0002055'>diabetes</z:mp> are similar or different <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>We have investigated the immunological and metabolic differences between type 1, type 1.5, and classic type 2 diabetic patients </plain></SENT>
<SENT sid="8" pm="."><plain>We have identified autoantibody differences, differences in islet proteins recognized by T-cells, and differences in <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>We have also identified a small group of patients who have T-cells responsive to islet proteins but who are autoantibody negative </plain></SENT>
<SENT sid="10" pm="."><plain>These patients appear to be similar to type 1.5 patients in having decreased stimulated C-<z:chebi fb="7" ids="16670">peptide</z:chebi> values </plain></SENT>
<SENT sid="11" pm="."><plain>These immunological differences between type 1 and type 1.5 <z:mp ids='MP_0002055'>diabetes</z:mp> suggest at least partially distinct disease processes </plain></SENT>
</text></document>